Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair
Simple Summary
- Supplementary File 1:
PDF-Document (PDF, 1029 KiB)
Elsesy, M.E.; Oh-Hohenhorst, S.J.; Löser, A.; Oing, C.; Mutiara, S.; Köcher, S.; Meien, S.; Zielinski, A.; Burdak-Rothkamm, S.; Tilki, D.; Huland, H.; Schwarz, R.; Petersen, C.; Bokemeyer, C.; Rothkamm, K.; Mansour, W.Y. Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair. Cancers 2020, 12, 2467. https://doi.org/10.3390/cancers12092467
Elsesy ME, Oh-Hohenhorst SJ, Löser A, Oing C, Mutiara S, Köcher S, Meien S, Zielinski A, Burdak-Rothkamm S, Tilki D, Huland H, Schwarz R, Petersen C, Bokemeyer C, Rothkamm K, Mansour WY. Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair. Cancers. 2020; 12(9):2467. https://doi.org/10.3390/cancers12092467
Chicago/Turabian StyleElsesy, Mohamed E., Su J. Oh-Hohenhorst, Anastassia Löser, Christoph Oing, Sally Mutiara, Sabrina Köcher, Stefanie Meien, Alexandra Zielinski, Susanne Burdak-Rothkamm, Derya Tilki, Hartwig Huland, Rudolf Schwarz, Cordula Petersen, Carsten Bokemeyer, Kai Rothkamm, and Wael Y. Mansour. 2020. "Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair" Cancers 12, no. 9: 2467. https://doi.org/10.3390/cancers12092467